Anavex Life Sciences Corp Share Price OTC Bulletin Board
Equities
AVXL
US0327971026
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 316M 26.37B |
---|---|---|---|---|---|
Net income 2024 * | -46M -3.84B | Net income 2025 * | -55M -4.59B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-6.75
x | P/E ratio 2025 * |
-6.02
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.86% |
Latest transcript on Anavex Life Sciences Corp
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 05/13/05 | |
Sandra Boenisch
DFI | Director of Finance/CFO | 43 | 01/15/01 |
Edward Hammond
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 05/13/05 | |
Tom Skarpelos
FOU | Founder | 57 | 23/04/23 |
Jiong Ma
CHM | Chairman | 60 | 25/21/25 |
1st Jan change | Capi. | |
---|---|---|
-1.43% | 104B | |
+8.96% | 105B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- AVXL Stock
- AVXL Stock